Skip to main content

IAVI 010

Phase:
IIa
Status:
Completed
Strategies:
DNA ; Viral Vector - Pox
Candidates:
DNA.HIVA MVA.HIVA
Countries:
Kenya;United Kingdom
Volunteers:
115
Partners:
Kenya AIDS Vaccine Initiative-Kenyatta National Hospital (KAVI-KNH), Nairobi, Kenya; St. Thomas’ Hospital, London, UK.

 

Study Summary:

This trial tests the safety and immunogenicity of a clade A HIV-DNA/MVA prime-boost combination, in HIV-uninfected healthy volunteers at low risk for HIV infection. In addition, the effect of the route of administration of the MVA boost will be studied.